EDAP TMS SA (EDAP) Stock Price, Financials & Summary

Price chart

May 28Jun 2Jun 5Jun 10Jun 15Jun 18Jun 24Jun 29

Key dataJun 29, 2026

Open$5.11

From 52W high−7.67%

Volume37978.00

Market cap$178.23M

P/E (TTM)—

P/S (TTM)2.5x

Div yield—

Key dataJun 29, 2026

Open

$5.11

From 52W high

−7.67%

Volume

37978.00

Market cap

$178.23M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.0x

P/E (TTM)

—

RSI (14)

72.7

MomentumView details →

1D Return

−0.52%

YTD Return

+56.53%

SummaryUpdated Jun 1, 2026

EDAP TMS S.A. (NASDAQ:EDAP) is a French medical device company founded in 1979 and headquartered in Lyon, France. The company went public in 1997 and specializes in developing, manufacturing, and marketing minimally invasive medical devices for treating urological diseases. EDAP has evolved from a diversified medical device company into one increasingly focused on its High Intensity Focused Ultrasound (HIFU) technology platform, particularly for prostate cancer treatment. The company operates globally with direct sales operations in the United States, Europe, and Asia, serving hospitals, urology clinics, and research institutions worldwide.

Ask drillr about EDAP TMS SA →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−7.0x

EV/Sales

2.3x

P/S (TTM)

2.5x

P/B (TTM)

17.6x

ProfitabilityView details →

Gross Margin

43.45%

Net Margin

−41.70%

EBITDA Margin

−32.69%

ROE (TTM)

−297.24%

ROA (TTM)

−41.67%

Asset Turnover

0.95x

GrowthView details →

Revenue YoY

+14.72%

EPS YoY

−32.28%

FCF YoY

+0.77%

Revenue CAGR 3Y

+8.68%

EPS CAGR 3Y

−52.94%

EBITDA YoY

−15.30%

MomentumView details →

1D Return

−0.52%

YTD Return

+56.53%

1Y Return

+212.12%

RSI (14)

72.7

vs 50D SMA

+22.25%

vs 200D SMA

+49.87%

Capital & dividendView details →

Debt/Equity

0.23x

Current Ratio

1.34x

Quick Ratio

0.99x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.24

EPS Surprise

−9.09%

Beats (12Q)

3/12

Next Q EPS Est

—

Avg Surprise (4Q)

−4.37%

Rev Surprise

8.24%

Financials snapshotView financials →

Revenue (TTM)

69.14M

Net Income (TTM)

−38.89M

Op. CF (TTM)

−13.11M

Latest newsMore news →

EDAP TMS SA announced a public offering expected to raise gross proceeds of $40 million.39d ago

EDAP TMS SA reported Q2 2026 revenue of $13.2 million, up 39% year-over-year, with a net loss of $14.5 million and diluted EPS of -$0.39.39d ago

Similar companies

Solana CompanyHSDT Quipt Home Medical Corp.QIPT Yestar Healthcare Holdings Company Limited02393.HK Lucid Diagnostics Inc.LUCD Rainmed Medical Limited02297.HK Profound Medical Corp.PROF Find similar companies →

Latest newsMore news →

EDAP TMS SA announced a public offering expected to raise gross proceeds of $40 million.39d ago EDAP TMS SA reported Q2 2026 revenue of $13.2 million, up 39% year-over-year, with a net loss of $14.5 million and diluted EPS of -$0.39.39d ago